Ontology highlight
ABSTRACT:
INSTRUMENT(S): LTQ Orbitrap Velos
ORGANISM(S): Trypanosoma Brucei
DISEASE(S): Trypanosomiasis
SUBMITTER: Michael Urbaniak
LAB HEAD: Alan Fairlamb
PROVIDER: PXD002848 | Pride | 2015-11-25
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
DJ-1.raw | Raw | |||
DJ-2.raw | Raw | |||
MQ-search.zip | Other | |||
TableS1QuantitativeproteomicanalysisofOxaboroletargets.xlsx | Xlsx |
Items per page: 5 1 - 4 of 4 |
Jones Deuan C DC Foth Bernardo J BJ Urbaniak Michael D MD Patterson Stephen S Ong Han B HB Berriman Matthew M Fairlamb Alan H AH
PLoS neglected tropical diseases 20151218 12
SCYX-7158, an oxaborole, is currently in Phase I clinical trials for the treatment of human African trypanosomiasis. Here we investigate possible modes of action against Trypanosoma brucei using orthogonal chemo-proteomic and genomic approaches. SILAC-based proteomic studies using an oxaborole analogue immobilised onto a resin was used either in competition with a soluble oxaborole or an immobilised inactive control to identify thirteen proteins common to both strategies. Cell-cycle analysis of ...[more]